• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti-Aging Studies
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for tumor

tumor

OMRF identifies potential ovarian cancer therapy

March 23, 2021

OMRF has discovered a targeted therapy that could improve treatment and long-term outcomes for ovarian cancer.

Filed Under: News Tagged With: Bieniasz, cancer, Magdalena, news, newsok, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, ovarian, precision medicine, scientist-news, Stephenson Cancer Center, tumor

Oblato acquires all rights to glioblastoma drug from OMRF

October 29, 2018

Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.

Filed Under: News, Technology Ventures News Tagged With: 007, americans, brain, cancer, clinical, deadly, diagnosis, drug, edward kennedy, Gtree, james battiste, john mccain, Manu Nair, mike schuster, model, news, Norman, Oblato, Oklahoma Medical Research Foundation, okn, OKN-007, OMRF, Rheal, rheal towner, robert floyd, scientist-news, Stephenson Cancer Center, technology, testing, therapy, Towner, treatment, trial, tumor, university of oklahoma

Staying alive: Can an experimental OMRF drug stop Mike Schuster’s brain cancer?

September 11, 2018

As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.

Filed Under: News, Technology Ventures News Tagged With: aggressive, battiste, brain, brain cancer, cancer, deadly, death, develop, disease, drug, glioblastoma, john mccain, life expectancy, live, longer, mike schuster, MRI, newsok, Norman, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OKN-007, OMRF, OUHSC, patients, Rheal, scientist-news, Stephenson Cancer Center, Towner, tumor

OMRF researchers identify genes that may cause cancer to recur after treatment

December 20, 2017

Cancer often returns after successful therapy, but why?

Filed Under: News Tagged With: basic research, bioinformatics, block, cancer, cancer stem cells, candidate genes, cells, computer, function, Gary, gary gorbsky, genes, Gorbsky, growth, inhibit, Jonathan, jonathan wren, model, news, newsok, OKC, Oklahoma Medical Research Foundation, OMRF, paper, pathway, protein, publish, resurgence, return, scientist-news, stem cells, test, theory, therapy, treatment, tumor, Wren

Military academy students get hands-on lab experience at OMRF

June 29, 2017

The Saxon program provides military academy students with an opportunity to work alongside OMRF senior scientists.

Filed Under: News Tagged With: academy, air force, army, cadet, cancer, Courtney, development, education, erin mcshane, grant, Griffin, Humphries, jocelyn rodriguez, John Saxon, kenneth, lab, matthew lerdahl, midshipmen, military, Muskogee, naval academy, Navy, newsok, ok, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, opportunity, Pezza, program, research, Roberto, Saxon, scholarship, science, scientist-news, tumor, united states, us, usaf

OMRF scientists identify protein that could drive colon cancer process

June 10, 2015

Research team’s new findings recently published in Nature Communications.

Filed Under: News Tagged With: baojun chang, cancer, colon cancer, development, hong chen, kandice tessneer, nature communications, nonprofit, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, ph.d., protein, research, role, science, tumor, wnt signaling

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayGive Smart OKCTop Workplace